3- Effects on Liver Steatosis and Overall Metabolic Health : Beyond weight and glucose control, retatrutide has shown promise in reducing liver fat accumulation [5] (liver steatosis), a frequent complication in obesity and diabetes
However, some individuals may experience mild side effects such as: Slight discomfort or bruising at the injection site Temporary lightheadedness or dizziness A cool sensation in the arm during infusion Serious side effects are rare, but if you have any underlying health conditions, its always best to consult with a healthcare professional before starting IV therapy
A multivariable Cox proportional hazards model was used to evaluate the association between living alone and the risk of developing ESKD
The authors stated that CKD is a common complication of T2D, and that glucagon-like peptide-1 receptor agonists (GLP-1RAs) can both improve glycaemic control and lower body weight in people with T2D and reduce the risk of cardiovascular (CV) events in those with high CV risk. According to Rossing et al , GLP-1RAs might also have kidney-protective effects. One of the reasons that they decided to undertake this study was that, to date, data have mostly been derived from CV outcome or glycaemic control trials featuring populations not selected for CKD and/or with kidney disease events as secondary outcomes
It can also help improve blood sugar levels, which is particularly beneficial for individuals with prediabetes or type 2 diabetes
Surgical colectomy becomes necessary in approximately 10-15% of patients with contemporary medical therapy, though rates vary by disease severity and treatment era